Next Generation Cellular News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Next Generation Cellular. Real-time updates on events, politics, business and more.

Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-101, Produces Active and Sustained Levels of Factor IX for the Treatment of Hemophilia B

December 10, 2023

SAN DIEGO--(BUSINESS WIRE)--Dec 10, 2023--

United States San Diego Richard James Joanne Smith Farrell Richard Morgan David Rawlings

Source: valdostadailytimes.com

NKILT Therapeutics announces oral presentation featuring Chimeric ILT-Receptor (CIR™) engineered NK cells at the 65th ASH Annual Meeting and poster presentation at the 38th SITC Annual Meeting

November 3, 2023

/PRNewswire/ -- NKILT Therapeutics, Inc., a preclinical-stage cell therapy biotech company developing proprietary Chimeric ILT-Receptor (CIR™)–engineered...

San Diego Convention Center United States San Diego Mylinh Duong Chris Conley J Henri Bayle

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Next Generation Cellular News Today

Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-101, Produces Active and Sustained Levels of Factor IX for the Treatment of Hemophilia B

NKILT Therapeutics announces oral presentation featuring Chimeric ILT-Receptor (CIR&#x2122;) engineered NK cells at the 65th ASH Annual Meeting and poster presentation at the 38th SITC Annual Meeting

Explore More Categories

NKILT Therapeutics announces oral presentation featuring Chimeric ILT-Receptor (CIR™) engineered NK cells at the 65th ASH Annual Meeting and poster presentation at the 38th SITC Annual Meeting